Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil.
Hilger
R A
RA
Department of Internal Medicine (Cancer Research), University of Essen Medical School, West German Cancer Center, Essen, Germany. ralf.hilger@uni-essen.de
Richly
H
H
Grubert
M
M
Oberhoff
C
C
Strumberg
D
D
Scheulen
M E
ME
Seeber
S
S
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D003692:Delayed-Action Preparations; D004317:Doxorubicin / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D009369:Neoplasms / Q000378:metabolism*
D000903:Antibiotics, Antineoplastic; D003692:Delayed-Action Preparations; D008081:Liposomes; D004317:Doxorubicin